The need for novel drugs to treat diseases affecting central nervous system (CNS) is increasing. Large pharma companies are pursuing for new ideas and projects from research organizations and micro-to-small companies. Research organizations are increasingly willing to commercialize their innovations, while small companies are devoted to expand their operations.
Research on drug targets, discovery of treatment principles and development of drug candidates is done in the networks of specialists. Oy Sauloner Ltd wishes to be the player in those networks.